Bausch Health Companies Inc (BHC): ORTHO DERMATOLOGICS TO PRESENT SILIQ™ (B...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Bausch Health Companies Inc (BHC)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	8
Posts	508
Boards Moderated	0
Alias Born	07/04/2014

Re: None

Thursday, 10/12/2017 3:26:26 AM

Thursday, October 12, 2017 3:26:26 AM

ORTHO DERMATOLOGICS TO PRESENT SILIQ™ (BRODALUMAB) INJECTION DATA FROM PIVOTOL PHASE III CLINICAL TRIAL AT FALL CLINICAL DERMATOLOGY CONFERENCE

link to news
link to news pdf

RALEIGH, N.C., Oct. 10, 2017 – Ortho Dermatologics, one of the largest prescription dermatology businesses in the world, announced today that results from the SILIQ™ pivotal Phase 3 long-term extension study will be presented at the Fall Clinical Dermatology Conference in Las Vegas on October 12 – 15, 2017. In total, six new abstracts will be presented, including new data about the long-term efficacy of SILIQ, the efficacy of SILIQ in ustekinumab-naïve and -experienced patients with moderate-to-severe plaque psoriasis, as well as the impact of SILIQ treatment on health-related quality of life.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent BHC News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:24:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:19:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:16:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 03:36:17 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 10:04:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:04:41 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:30:26 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/08/2024 02:00:18 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 10:18:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:19:47 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:18:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:16:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:15:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:35:35 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/05/2023 04:12:39 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/13/2023 09:50:05 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2023 10:06:25 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/06/2023 04:09:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 08:58:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 11:05:39 AM
Bausch Health Gets FDA Approval for Acne Treatment Cabtreo • Dow Jones News • 10/20/2023 10:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:29:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:28:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:27:19 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:25:30 PM

More BHC News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow